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SR Ca ~+ uptake rate, measured with the fluorescent Ca ;~+ indicator Furs-2, 
was eignlficangy decreased in fat!trig compared to nonfailing SR vesicles 
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Protein levels of SR Ca 2+ ATPase (Western blot analysis) showed no 
differences between feUinq and nonfailing left ventricles. Conclusion: Over 
phySiolugtcal rang~ of [CaZ÷], the SR uptake is impaired in failing hearts. 
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Expression of Protein Kinase C Isoforrss In Human 
. . . .  Heart: Evidence for an Isofcrm Shllt in Developing 
Hear~ and in Chronic Heart Failure 
Ruth H, Strasser, Sts6en K. Bdem, RQdlgar Lange, Christian F. Vaht, 
Siegfried Haul, Ralner Marquetent, Wolfgang K0bler, University of 
Heidelberg, Germany 
Protein kinase C (PKC) a key enzyme of the phesphatidylinasitol system 
may mediate growth and hypertrophy. It also has been shown to play an 
important role in cardiac ischeml¢ preconditioning, It is not known which of 
the isoformS of PKC am expressed in human heart or if their expression may 
be modulated in failing and developing human heart. To address these issues 
biopsies of human left ventricles and right atria were analyzed. The samples 
were taken from adult donor or ,'ailing hearts at the lime of vansplantantion 
or from infant hearts (6 weeks up to 3 years~ with ventricle septel defects at 
time of operation. PKC isoforms were analyzed using Western blot a;mlysis 
with isofomvspeclfic peptida antibodies, 
In normal left vontrisles PKC~, -e, ~ and *,6 are expmesed, whereas 
PKC-~, -), or -0 could not be detected, in contrast, in dght atxia only PKC-~. 
-~ and -¢', but not -p are express~.~d. In failing human left ventricle PKC~/~ 
was slgniffP-.antiy InCreased to 240% compared to adult controls, In dgnt atria 
PKC,-,8 could not be discovered in normal or failing human hearts. However, 
in infants PKC*p is expressed at high levels in right atria with age*related, 
decreasing intensities, 
These data characterize for the first time the specific isoforms of PKC in 
human heart and their distinct regulation in early growth and in chronic head 
failure. PKC-p is Increased in failing human left venldcles and is expressed 
in dght atria only in infant heedS demonstrating an isoform shift in failing and 
developing he,u1. The understanding of these newly characterized istinct 
regulation processes may help to further characterize their role In cardiac 
growth and hypertrophy in the young and in the patients with congestive 
heart failure. 
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Aortle Valve Replecemettt In Children 
Ravlan M. Luptnstti, Thomas K, Jones, $, Paul Hemdon. C, hiidran's 
Hospital and Medical Center, SaM#e, Washington; The University of 
Washington, Seattle, Washington 
Aodio valve replacement (AVR) in children is complicated by the difficult 
management required for mechanical valves and the uncertain outcome fol- 
lowing the use of human valves. The results of AVRs performed from 1990 
through August, 1995, at ane children's hospital were reviewed. Mechani- 
c, el valves worn USed ~xcluSivaly through 1993 (n = 25). Starting in 1994, 
21 conse(:utive AVRs were perfomled as Ross procedures (17) or allograft 
AVRs (4). Alicgrafts were used for petiant~; with Marfan's yndrome or those 
whose previous operations rendered the pu!monary autograft unusable. In 
the Ross/allagraft group, patient age was 2-15 years (mean 9 yeas) and 
weight was 11"--66 kg (mean 34 kg), compared to 2-18 years (mean 12 years) 
and 12-110 kg (mean 47 kg) in the mechanical group. In the Ress/allograft 
groin, 13 patients underwent 19 prior surgical procedures including 2 pre. 
vious AVRs with rnect'mnical valves, and 3 additional patients underwsnt 
balloon valvotom!;. In the r,~echanical AVR group, 17 patients underwent 17 
prior operations, including 2 mechanical AVRs, Operative complications in- 
cluded 1 pacemaker for heart block and 1 mild stroke in the Rc;.s,'ailograft 
group and 2 deaths, 1 eady re, operation for endocarditis, and 2 pacemakers 
in the mechanical AVR group. In the Ress/all~lreft group there were no late 
complications or reeporations. In the mechanical AVR group, late complice. 
lions included S cases of nonstructural degeneration, 3 of which requir,~l 
reoperation. Reopemnon-free survival in the Ros~/allograft group was 100% 
at 1S months, Reoparation-free sun/ivel in the mechanical AVR group was 
83*/= at 18 months (0.10 < p < 0.05 VS. the Rass/allagmft group} and 74% at 
48 months These data call into question the permanence of mechanical AVR 
in children. AVR with the Ross procedure or with allografts can be canied Out 
unifom~ly in children with beftar early results than mech~!'.;al AVR. Longer 
follow-up will be necessen] to confirm the Superiority of AVR with human 
tissues, 
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~ Intermediate Outcome of the Ross Procedure in 
Ch i ld ren  
Susan E. desJardtnu, Amnon flesenthal, Ralph S, Moses, Edward L Beve. 
University of Michigan, Ann Arbor, MI 
Although the Ross procedure is commonly used in patients requiring aortic 
valve replacement, minirrPJ data am available on the risks and outcome in 
children. We reviewed our experience with 33 consecutive pediatric pts (age 
4 days to 20 yrs; median 8 yrs) who underwent a Ross procedure at Our 
institution from 10/91 to 8/95. Information obtained included preoperative 
and pOStoperative clinical, echeoardtographic, and herrK~:lynarnic data. Indi- 
cation~ for the Ross procedure were aortic stanosis (AS) and regurgitation 
(AR) (n == 14), AR alone (n = 10), and AS alone (n = 9). Pdor procedures 
included balloon valvuloptssty (n = 8) and surgical valvotomy (n = 9), Major 
complications dudng hospitalization i cluded reoperation for blee~ng (n = 2), 
myocardial ischemia (n = t), complete heart block (n = 1), and endocarditis 
(n = t), N133 pts survived the initial hospitalization. Left ventricul=" outflow 
tract obstmcttno was relieved in all pts (PIPG < 17 mmHg). There was no 
or mi;d AR at hospital discharge in 31 of 33 pts, with mnderato AR in 2 pts. 
Sun~ival dudng a follow up period of 0-.46 months (mean = 16 months) was 
97% (32/33). Of the 17 pts with serial echocardiegraphic data, progressive 
AR was seen only in those 2 who had me.rate AR on discharge. Late com- 
pllcetlons Occurred in 4 of 7 pts under 2 yrs of age and included ventdcular 
failure and death (n = I), re.trent severe AR (n = I), RV to PA homograft 
caldfication requiring replacement and mitral etenosis (n = 1), and mitral 
regurgitation (  = 1). We conclude that the Ross procedure results in gaed 
intermediate outcome in c~ildren of all ages, even neonates, with resolution 
of AS and minimal residual AR. The high prevalence of late complications in
pts under age 2 yrs is related to complex as.~ociated cardiac disease, The 
Ross procedure al~ears to be a safe and effective method ot aortic valve 
replacement in children. 
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Arterial Switc:h Repair (ASR) for Simple 
" Transposition of the Great Arteriss (TGA) In infants 
Older Than 21 Days 
John P. Foran, lan D. SuTliVan, Marlin J. Ellictt, Marc R. de Leval, Great 
Ormond Street Hospital for Children, London, UK 
Surgical management of simple TGA beyond the age of 21 days is contro- 
versial, Concern that regression of left vantdcular (LV) myocardial mass will 
render the LV incapable of coping with the acuity increaSed work of systemic 
pedusion has been considered a ¢ontraindication toASR, 
Between January 1990 and March 1995 ASR was performed in 22 infants 
aged 21 tO 58 (madmn 31) clays with simple TEA, Group A. Dudng the same 
era, ASR was performed in 115 neonates with simple TGA aged _< 20 days, 
Group B. Hospital mortality was 1/22 (4.5%) arct 12/',i5 (10.4%) respec- 
tively (p = NS) with one late death in Group B, No patient was receiving 
pmslaglandin at the time of ope~tion. The patient in Group A who died was 
the smallest at operation (2.1 kg, aged 57 days) who also had cleft palate, 
respiratory failure and systemic pulmonary artery pressure pre*Ol~.~ratively 
and died after ASR of probable pulmonary hypertensive crisis. In Group A, 
age, LV mass index, LV posterior wall thickness index, LV volume index, LV 
messNolume ratio, patent adedal duct diameter > 2 mm or coronary anatomy 
did nOt predict death, duP,=tino f post operative ventilation or inotreplc sup- 
